IONQ Inc vs Health Care Select Sector SPDR Fund — how do they compare? IONQ Inc trades at $35.61 (market cap $12.78B), while Health Care Select Sector SPDR Fund trades at $159.37. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, IONQ Inc nearer its low. Which is the better fit depends on your goals.
| IONQ | XLV | |
|---|---|---|
Market Cap | $12.78B | — |
Sector | Technology | — |
52-Week High | $82.09 | $164.48 |
52-Week Low | $26.59 | $129.01 |
Enterprise Value | $10.78B | — |
Signals from Pluang's Aura AI — not financial advice
IONQ trades at $34.24, down 1.55% with a bearish technical signal despite bullish oscillators. The company shows strong revenue growth projections from $130M in 2025 to $187M in 2026, but remains unprofitable with a net loss of $510M in 2025. Analyst consensus is split with a $73.75 price target representing 115% upside potential. Recent news highlights IonQ's leadership in quantum computing platform development and government validation.
The stock offers significant upside potential based on analyst targets but faces execution risks in achieving profitability. High valuation multiples (P/E 89.18, P/S 58.73) reflect growth expectations, while negative cash flow from operations and competitive threats in quantum computing present substantial risks for investors.
XLV trades at $159.25, down 1.14% on the day, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The healthcare ETF faces mixed sentiment with recent positive sector upgrades from State Street Investment Management but concerns about sector headwinds during earnings season. Support levels cluster around $158-160, while resistance sits at $163-165.
The healthcare sector offers defensive characteristics amid market volatility, with XLV providing diversified exposure. Key risks include patent cliffs for major holdings and election-year policy uncertainty. Analyst sentiment is cautiously optimistic given the sector's stability and innovation pipeline, though relative performance versus technology remains a concern.
Trailing returns across standard periods
Latest headlines on both assets
IonQ is a leader in quantum computing, developing world-class quantum systems. Its technology aims to solve complex problems across finance, healthcare, and materials science that are beyond classical computers.
Read more on IONQ →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →